Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Borderline Resectable Pancreatic Ductal Adenocarcinoma”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Testing effectiveness (Phase 2)Looking for participantsNCT05851924
What this trial is testing

NALIRIFOX in Combination With Radiation Therapy in People With Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Memorial Sloan Kettering Cancer Center 60
Not applicableUnknownNCT04855331
What this trial is testing

Laparoscopic Versus Open Pancreatoduodenectomy Following Neoadjuvant Chemotherapy for BRPC

Who this might be right for
Borderline Resectable Pancreatic Cancer
Fudan University 120
Testing effectiveness (Phase 2)UnknownNCT02926183
What this trial is testing

Study of NAC of GA Therapy for Patients With BRPC

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Wakayama Medical University 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07616362
What this trial is testing

Personalize (Signature Driven) Neoadjuvant Chemotherapy Trial for Patients With Resectable Borderline Pancreatic Ductal Adenocarcinoma.

Who this might be right for
Borderline Resectable Pancreatic Ductal Adenocarcinoma
Federation Francophone de Cancerologie Digestive 110
Early research (Phase 1)Study completedNCT04106856
What this trial is testing

Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaLocally Advanced Unresectable Pancreatic Adenocarcinoma+4 more
University of Utah 22
Early research (Phase 1)Looking for participantsNCT06141031
What this trial is testing

Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Washington University School of Medicine 24
Testing effectiveness (Phase 2)Study completedNCT03496662
What this trial is testing

BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Washington University School of Medicine 40
Testing effectiveness (Phase 2)Ended earlyNCT04176952
What this trial is testing

PRIMUS002: Looking at 2 Neo-adjuvant Treatment Regimens for Resectable and Borderline Resectable Pancreatic Cancer

Who this might be right for
Neoplasms Pancreatic
Judith Dixon-Hughes 31
Early research (Phase 1)Looking for participantsNCT07619313
What this trial is testing

AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaLocally Advanced CholangiocarcinomaLocally Advanced Pancreatic Adenocarcinoma+5 more
Jonsson Comprehensive Cancer Center 46
Large-scale testing (Phase 3)Active Not RecruitingNCT04793932
What this trial is testing

Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL)

Who this might be right for
Pancreas Ductal Adenocarcinoma
Associazione Italiana per lo Studio del Pancreas 261
Not applicableLooking for participantsNCT06320717
What this trial is testing

AI Derived Biomarker to Select Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Roswell Park Cancer Institute 100
Testing effectiveness (Phase 2)Study completedNCT05262855
What this trial is testing

Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma

Who this might be right for
PDAC - Pancreatic Ductal AdenocarcinomaFAP
SOFIE 63
Testing effectiveness (Phase 2)Ended earlyNCT01431794
What this trial is testing

Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 23
Testing effectiveness (Phase 2)Study completedNCT02125136
What this trial is testing

Trial to Investigate Intensified Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer

Who this might be right for
Ductal Adenocarcinoma of the Pancreas
AIO-Studien-gGmbH 168
Not applicableStudy completedNCT05888129
What this trial is testing

Clinical Outcomes of Surgery After Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer

Who this might be right for
Postoperative Complications
Asan Medical Center 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07748611
What this trial is testing

SMAD4 Tailored Neoadjuvant Therapy for the Treatment of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma, SMART-PANC Trial

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal Adenocarcinoma
Northwestern University 125
Testing effectiveness (Phase 2)Looking for participantsNCT05688215
What this trial is testing

Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal Adenocarcinoma
Jonsson Comprehensive Cancer Center 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06573398
What this trial is testing

Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC

Who this might be right for
Carcinoma, Pancreatic Ductal
Ruijin Hospital 20
Testing effectiveness (Phase 2)WithdrawnNCT03038477
What this trial is testing

Durvalumab in Patients With BR PDA Following Neoadjuvant Therapy and Successful Surgical Resection

Who this might be right for
Pancreatic Cancer
University of Colorado, Denver
Testing effectiveness (Phase 2)Looking for participantsNCT07269626
What this trial is testing

PULSAR in Systemic Therapy for Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Ductal AdenocarcinomaBorderline Resectable Pancreatic Ductal AdenocarcinomaOligometastatic Pancreatic Ductal Adenocarcinoma
Samsung Medical Center 47
Next Page